Two Weeks Too Long: Optimal Duration for Ureteral Prestenting and Its Physiologic Effects on the Ureter in a Yorkshire-Landrace Pig Model

2019 ◽  
Vol 33 (4) ◽  
pp. 325-330 ◽  
Author(s):  
Kheng S. Lim ◽  
Yong W. Lim ◽  
Daniel Z.P. Yong ◽  
Ying Hao ◽  
Henry S.S. Ho ◽  
...  
Keyword(s):  
Pig Model ◽  
Optimal Duration ◽  
Landrace Pig

Comparsion of difference donar for lung transplantation at pig model

2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
S Lehmann ◽  
C Topf ◽  
M Dieterlein ◽  
J Garbade ◽  
S Leontjev ◽  
...  
Keyword(s):  
Lung Transplantation ◽  
Pig Model

Idiopathic venous thrombosis

2006 ◽  
Vol 26 (01) ◽  
pp. 52-54 ◽  
Author(s):  
P. A. Kyrle
Keyword(s):  
Chronic Disease ◽  
Venous Thrombosis ◽  
Vitamin K ◽  
Clinical Benefit ◽  
Plasma Levels ◽  
Vitamin K Antagonists ◽  
Antithrombin Deficiency ◽  
Optimal Duration ◽  
Risk Of Treatment

SummaryVenous thrombosis is a chronic disease with a recurrence rate of approximately 30% within 5-8 years. The optimal duration of secondary thromboprophylaxis in these patients entails balancing the risk of recurrence against the risk of treatment-associated bleeding. There is agreement that patients with a first idiopathic venous thrombosis should receive vitamin K antagonists for at least 3-6 months. Convincing trials showing a clinical benefit in terms of morbidity or mortality with respect to expansion of anticoagulation beyond 6 months are lacking. Nevertheless, some subgroups of patients with venous thrombosis may benefit from indefinite anticoagulation. Thus, patients with antithrombin deficiency, combined or homozygous defects, more than one unprovoked episode of thrombosis, the lupus anticoagulant or high factor VIII plasma levels are good candidates for long-term prevention.

Sign in / Sign up

Export Citation Format

Share Document